James S Porterfield Prize
in International Virology
The 2017 Prize has been awarded to three students this year
- Marios Koutsakos, a PhD student at the University of Melbourne, whose Proposed Project is entitled “CD8+ T cell responses to Influenza B viruses in children”, and will be with Paul Thomas, at St Jude’s Children Hospital, USA
- Raquel Medialdea-Carrera, studying for a PhD at University of Liverpool, whose Proposed Project is entitled “Investigation of the spread of Zika Virus in the State of Rio de Janeiro since 2013”, and will be at the Flavivirus Reference Laboratory – Oswaldo Cruz Institute – Fiocruz, Rio de Janeiro (BRAZIL)
- Christopher Roundy, studying for a PhD at University of Texas Medical Branch, whose Proposed Project is entitled “Microbiome and Immune Factors Related to Vector Competence of Aedes aegypti for Zika and Chikungya Virus”, and will be at Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Brazil
The prize (US$1,000) is awarded by open competition to students of virology registered for a degree at any University worldwide.The prize can contribute towards the costs of travel, subsistence, fees and expenses of the student in connexion with a piece of research to be conducted by the student at an institution and in a country other than their own. The criteria for award will be the academic promise of the student and the likely value of the research to science or medicine and the student’s scientific education.
Eligible projects will be those in virology that require international travel, and preference will be given for field or laboratory work on arboviruses.
The 2016 Prize was won by:
- Alberto Domingo López Muñoz, a PhD student at the “Severo Ochoa” Centre for Molecular Biology, Madrid. The project will be to work with in Peter O’Hare’s lab, Imperial College London, on “the role of glycoprotein G from Herpes simplex virus in cellular migration”. His final report is here.
Lalita Priyamvada, Ph.D. Candidate at Emory University, Atlanta, GA USA. The project is to work with Dr. Anmol Chandele at the Joint International Centre of Genetic Engineering and Biotechnology – Emory Vaccine Center (ICGEB-‐EVC), New Delhi, India, on the primary and secondary plasmablast responses to dengue virus infection